Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-602-4 | CAS number: 72363-26-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Disperse Red 092 was found to be non-mutagenic in a bacterial reverse mutation assay. Hence, in order to fulfil the data requirements of Annex VIII of Regulation (EC) 1907/2006, data from read-across substances has been used. The read-across substance FAT 36034/W was non-mutagenic in a mammalian cell gene mutation assay (HPRT). Hence, on the basis of read-across principles, Disperse Red 092 was considered to be non-mutagenic.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 March 2016 to 09 June 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material:
PCR92X140707 (China)
- Expiration date of the lot/batch:
14 October 2019
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material:
2-8 °C, protected from light - Target gene:
- The Salmonella strains contain mutations in the histidine operon, thereby imposing a requirement for histidine in the growth medium. These strains contain the deep rough (rfa) mutation, which deletes the polysaccharide side chain from the lipopolysaccharides of the bacterial cell surface. This increases cell permeability of larger substances. The other mutation is a deletion of the uvrB gene, which codes for a protein of the DNA nucleotide excision repair system, resulting in an increased sensitivity in detecting many mutagens. This deletion also includes the nitrate reductase (chi) and biotin (bio) genes (bacteria require biotin for growth). Tester strains TA98 and TA100 contain the R-factor plasmid, pKM101. These strains are reverted by a number of mutagens that are detected weakly or not at all with the non-R-factor parent strains. pKM101 increases chemical and spontaneous mutagenesis by enhancing an error-prone DNA repair system, which is normally present in these organisms. The tester strain Escherichia coli WP2 uvrA carries the defect in one of the genes for tryptophan biosynthesis. Tryptophan-independent mutants (revertants) can arise either by a base change at the site of the original alteration or by a base change elsewhere in the chromosome so that the original defect is suppressed. This second possibility can occur in several different ways so that the system seems capable of detecting all types of mutagens, which substitute one base for another. Additionally, the strain is deficient in the DNA nucleotide excision repair system.
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9
- Test concentrations with justification for top dose:
- In the preliminary toxicity assay, the dose levels tested were 6.67, 10.0, 33.3, 66.7, 100, 333, 667, 1000, 3333 and 5000 µg per plate. In the mutagenicity assay, the dose levels tested were 50.0, 150, 500, 1500 and 5000 µg per plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: DMSO was the vehicle of choice based on the solubility of the test substance and compatibility with the target cells. The test substance in DMSO formed a clear solution at a concentration of approximately 25 mg/mL and workable suspensions at concentrations of approximately 30 to 250 mg/mL in the solubility test conducted at BioReliance. - Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- TA98, TA1535, TA100, TA1537 and WP2 uvrA - WIth S9 activation
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA98 -Without S9 activation
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- TA100, TA1535 without S9 activation
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA1537 - without S9 activation
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- WP2 uvrA - without S9 activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 to 72 hours
NUMBER OF REPLICATIONS: 1 in the preliminary toxicity assay; 3 in the mutagenicity assay
NUMBER OF CELLS EVALUATED: >/= 0.3 x 10 E8 cells/plate
DETERMINATION OF CYTOTOXICITY
- Method: other: Counting of revertant colony numbers and evaluation of the condition of the bacterial background lawn. - Evaluation criteria:
- The revertant colony numbers were determined for each plate (counted either manually or by automatic colony counter). The mean and standard deviation of the number of revertants per plate were calculated and reported. For the test article to be evaluated positive (mutagenic), it must cause a dose-related increase in the mean revertants per plate of at least one tester strain over a minimum of two increasing concentrations of test article as specified below:
Strains TA1535 and TA1537:
Data sets were judged positive if the increase in mean revertants at the peak of the dose response was equal to or greater than 3.0-times the mean vehicle control value.
Strains TA98, TA100 and WP2 uvrA:
Data sets were judged positive if the increase in mean revertants at the peak of the dose response was equal to or greater than 2.0-times the mean vehicle control value.
An equivocal response is a biologically relevant increase in a revertant count that partially meets the criteria for evaluation as positive. This could be a dose-responsive increase that does not achieve the respective threshold cited above or a non-dose responsive increase that is equal to or greater than the respective threshold cited. A response was evaluated as negative if it was neither positive nor equivocal. - Statistics:
- According to the test guidelines, the biological relevance of the results is the criterion for the interpretation of the results, and a statistical evaluation of the results is not regarded as necessary.
- Key result
- Species / strain:
- other: TA98, TA1535, TA100, TA1537 and WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- FAT40444/B considered as non-mutagenic with any of the tester strains in either the presence or absence metabolic activation.
- Executive summary:
The test substance, FAT40444/B, was tested to evaluate its mutagenic potential by measuring its ability to induce reverse mutations at selected loci of several strains of Salmonella typhimurium and at the tryptophan locus of Escherichia coli strain WP2 uvrA in the presence and absence of an exogenous metabolic activation system. The study was carried out according to OECD 471 guideline. Dimethyl sulfoxide (DMSO) was used as the vehicle. In the preliminary toxicity assay, the dose levels tested were 6.67, 10.0, 33.3, 66.7, 100, 333, 667, 1000, 3333 and 5000 µg per plate. No background lawn toxicity was observed. Precipitate was observed beginning at 667 µg per plate. Based upon these results, the maximum dose tested in the mutagenicity assay was 5000 µg per plate. In the mutagenicity assay, the dose levels tested were 50, 150, 500, 1500 and 5000 µg per plate. No toxicity was observed. Precipitate was observed beginning at 1500 µg per plate. No positive mutagenic responses were observed with any of the tester strains in either the presence or absence of S9 activation. The vehicle and positive control values indicate that all criteria for a valid assay were met. Based on the test results, FAT 40444/B was negative for the ability to induce reverse mutations at selected loci of several strains of Salmonella typhimurium and at the tryptophan locus of Escherichia coli strain WP2 uvrA in the presence and absence of an exogenous metabolic activation system.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
No in vivo genetic toxicity study is available with Disperse Red 092. However, read-across substance FAT 36034/D was found to be non-clastogenic in a micronucleus assay. Hence, on the basis of read across principles, Disperse Red 092 was considered to be not-clastogenic. Currently no in vitro study is available to evaluate effects on chromosomal level in eucaryontic cells. Since in vivo data for one read-across substance are available and in vitro data for a second read-across substance to cover clastogenic effects potentially caused by the test substance the respective in vitro assay is waived for the target substance.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Refer chapter 13 for detailed read-across justification.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- Based on the read across data generated from the in vivo micronucleus assay with FAT 36034/D, the Disperse Red 092 is also considered as non-clastogenic.
- Executive summary:
Data on clastogenicity was not available for the target substance (Disperse Red 092). To fill the data gaps, read-across approach is adapted using similar substance Disperse Red 086 (FAT 36034/D). Read-across is claimed basis of structural relationship of the target and the source chemicals. Read-across substance is FAT 36034/D and have been investigated for clastogenicity. A GLP-compliant OECD guideline 474 study was performed to investigate the potential of FAT 36034/D to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse. The following dose levels of the test article were investigated: 24 h preparation interval: 200, 670 and 2000 mg/kg b.w., 48 h preparation interval: 2000 mg/kg b.w.. The highest guideline-recommended dose (2000 mg/kg) was estimated by a pre-experiment to be suitable. The animals expressed slight toxic reactions. After treatment with the test article the number of NCEs was not increased as compared to the corresponding negative controls thus, indicating that FAT 36034/D had no cytotoxic effectiveness in the bone marrow. In comparison to the corresponding vehicle controls, there was no substantial enhancement in the frequency of the detected micronuclei at any preparation interval after administration of the test article and with any dose level used. 20 mg/kg b.w. cyclophosphamide administered was used as positive control which showed a statistically significant increase of induced micronucleus frequency. In conclusion, it can be stated that during the study described and under the experimental conditions reported, the read-across substance did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse. Therefore, the target substance, Disperse Red 092 is also considered to be non-clastogenic in the in-vivo micronucleus assay.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Bacterial reverse mutation assay with FAT 40444/B
The test substance, FAT40444/B, was tested to evaluate its mutagenic potential by measuring its ability to induce reverse mutations at selected loci of several strains of Salmonella typhimurium and at the tryptophan locus of Escherichia coli strain WP2 uvrA in the presence and absence of an exogenous metabolic activation system according to OECD guideline 471. Dimethyl sulfoxide (DMSO) was used as the vehicle. In the preliminary toxicity assay, the dose levels tested were 6.67, 10.0, 33.3, 66.7, 100, 333, 667, 1000, 3333 and 5000 µg per plate. No background lawn toxicity was observed. Precipitate was observed beginning at 667 µg per plate. Based upon these results, the maximum dose tested in the mutagenicity assay was 5000 µg per plate. In the mutagenicity assay, the dose levels tested were 50.0, 150, 500, 1500 and 5000 µg per plate. No toxicity was observed. Precipitate was observed beginning at 1500 µg per plate. No positive mutagenic responses were observed with any of the tester strains in either the presence or absence of S9 activation. The vehicle and positive control values indicate that all criteria for a valid assay were met. These results indicate FAT40444/B was negative for the ability to induce reverse mutations at selected loci of several strains of Salmonella typhimurium and at the tryptophan locus of Escherichia coli strain WP2 uvrA in the presence and absence of an exogenous metabolic activation system.
Mammalian cell gene mutation assay in vitro with FAT 36034/W (read across)
In a mammalian cell gene mutation assay (HPRT locus),V79 cells cultured in vitro were exposed to a read-across substance, FAT 36034/W at, concentrations up to 0.005, 0.25 mM (without and with metabolic activation). In experiment I without metabolic activation the highest mutation rate (compared to the solvent control values) of 1.54 was found at a concentration of 0.09 mM with a relative growth of 59.0%. In experiment I with metabolic activation the highest mutation rate (compared to the solvent control values) of 1.03 was found at a concentration of 0.06 mM with a relative growth of 92.8 %. In experiment II without metabolic activation the highest mutation rate (compared to the solvent control values) of 1.30 was found at a concentration of 0.01 mM with a relative growth of 75.7 %. In experiment II with metabolic activation the highest mutation rate (compared to the solvent control values) of 2.28 was found at a concentration of 0.085 mM with a relative growth of 78.2 %. The positive controls did induce the appropriate response. There was no evidence of a concentration related positive response of induced mutant colonies over background. Hence, the read across substance, FAT 36034/W, is considered to be non-mutagenic in the HPRT assay using V79 cells of the Chinese Hamster.
Micronucleus assay in vivo with FAT 36034/D (read-across)
A GLP-compliant OECD guideline 474 study was performed to investigate the potential of FAT 36034/D to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse. The following dose levels of the test article were investigated: 24 h preparation interval: 200, 670 and 2000 mg/kg b.w., 48 h preparation interval: 2000 mg/kg b.w. The highest guideline-recommended dose (2000 mg/kg) was estimated by a pre-experiment to be suitable. The animals expressed slight toxic reactions. After treatment with the test article the number of NCEs was not increased as compared to the corresponding negative controls thus indicating that FAT 36034/D had no cytotoxic effectiveness in the bone marrow. In comparison to the corresponding vehicle controls, there was no substantial enhancement in the frequency of the detected micronuclei at any preparation interval after administration of the test article and with any dose level used. 20 mg/kg b.w. cyclophosphamide administered was used as positive control which showed a statistically significant increase of induced micronucleus frequency. In conclusion, it can be stated that during the study described and under the experimental conditions reported, the test article did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse. Therefore, FAT 36034/D is considered to be non-clastogenic in this micronucleus assay.
FAT 40444/B was found to be non-mutagenic in a bacterial reverse mutation assay. Read-across substance, FAT 36034/W was found to be non-mutagenic in a mammalian cell gene mutation assay in vitro (HPRT), while read across substance, FAT 41034/A was non-clastogenic in a chromosomal aberration assay in vitro. Another read across substance, FAT 36034/A was non-clastogenic in a micronucleus assay in vivo. Hence, based on the negative bacterial reverse mutation assay with the substance and negative results from different read across substances in a mammalian cell gene mutation assay, a chromosomal aberration assay in vitro and an in-vivo micronucleus assay, the substance FAT 40444/B was considered to be not-genotoxic.
Justification for classification or non-classification
Based on the available genotoxicity study information, Disperse Red 092 does not considered to be classified for genotoxicity according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.